Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Machine Learning-Based Workflow for Predicting Transplant Outcome in Patients with Sickle Cell Disease

Haiou Li, Vandana Sachdev, Xin Tian, My-Le Nguyen, Matthew Hsieh, Courtney D. Fitzhugh, Emily Limerick, Wynona Coles, Nancy Asomaning, Anna Conrey, Colin O. Wu, Swee Lay Thein

Blood (2024) 144 (Supplement 1): 177.

https://doi.org/10.1182/blood-2024-194897

Published: 2024

Journal Articles

Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism

Rialnat A. Lawal, Devdeep Mukherjee, Emily M. Limerick, Wynona Coles, Matthew M. Hsieh, Laura W. Dillon, Christopher S. Hourigan, Courtney D. Fitzhugh

Blood (2022) 140 (23): 2514–2518.

https://doi.org/10.1182/blood.2022017960

Published: 2022

Journal Articles

Pentostatin Plus Cyclophosphamide Decrease Graft Rejection in Nonmyeloablative Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease

Emily Limerick, Mary Lacy Grecco, Julia Varga, Jennifer Brooks, Wynona Coles, R. AdeBisi Lawal, Neal Jeffries, Matthew M. Hsieh, Courtney D. Fitzhugh

Blood (2022) 140 (Supplement 1): 7572–7573.

https://doi.org/10.1182/blood-2022-169796

Published: 2022

Journal Articles

Bone Marrow Characterization in Sickle Cell Disease: Inflammation and Stress Erythropoiesis Lead to Suboptimal CD34 Recovery Compared to Normal Volunteer Bone Marrow

Alexis Leonard, MD, Aylin Bonifacino, MS, Venina Marcela Dominical, PhD, Anna Conrey, NP, Wynona Coles, Mary Link, RN, Matthew Hsieh, MD, Min Luo, PhD, Naoya Uchida, MD PhD, Francis J. Pierciey, Jr., John F Tisdale, MD

Blood (2017) 130 (Supplement 1): 966.

https://doi.org/10.1182/blood.V130.Suppl_1.966.966

Published: 2017

Journal Articles

At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT

Courtney D. Fitzhugh, Stefan Cordes, Tiffani Taylor, Wynona Coles, Katherine Roskom, Mary Link, Matthew M. Hsieh, John F. Tisdale

Blood (2017) 130 (17): 1946–1948.

https://doi.org/10.1182/blood-2017-03-772392

Published: 2017

Includes: Supplemental data

Journal Articles

At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation

Courtney D. Fitzhugh, MD, Matthew M. Hsieh, MD, Stefan Cordes, MD, Tiffani Taylor, PA, Wynona Coles, MPH, Katherine Roskom, RN, John F. Tisdale, MD

Blood (2016) 128 (22): 2483.

https://doi.org/10.1182/blood.V128.22.2483.2483

Published: 2016

Journal Articles

Prevalence of Anti-Human Factor VIII Binding IgG Antibodies in Sickle Cell Disease Patients before and after Hematopoietic Stem Cell Transplantation

Jay N Lozier, MD PhD, Eugene Park, BS, Chutima Kumkhaek, PhD, Mary E Link, BSN, Wynona Coles, MPH, Tiffani Taylor, PA, John F. Tisdale, MD, Matthew Hsieh, MD

Blood (2016) 128 (22): 3842.

https://doi.org/10.1182/blood.V128.22.3842.3842

Published: 2016

Journal Articles

Nonmyeloablative Hematopoietic Stem Cell Transplantation Improves a Marker of Diastolic Dysfunction in Patients with Sickle Cell Disease

Courtney Fitzhugh, MD, Hwaida Hannoush, MD, Vandana Sachdev, MD, Rosario Di Maggio, MD, Wynona Coles, RRT, Mary Link, RN, Evan Katradis, Xiongce Zhao, PhD, John F. Tisdale, MD, Matthew Hsieh, MD

Blood (2014) 124 (21): 4072.

https://doi.org/10.1182/blood.V124.21.4072.4072

Published: 2014

Journal Articles

Therapeutic Hydroxyurea Dosing Is Associated With Decreased Organ Damage and Longer Survival In Adults With Sickle Cell Anemia

Courtney Fitzhugh, MD, Darlene Allen, MT(ASCP), Wynona Coles, RRT, Michael Ring, MD, Xiongce Zhao, PhD, Matthew M. Hsieh, MD, James G Taylor, MD

Blood (2013) 122 (21): 2228.

https://doi.org/10.1182/blood.V122.21.2228.2228

Published: 2013

Journal Articles

Assessment Of The Endocrine Function Of Patients With Sickle Cell Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Helen Gharwan, MD, DSc, Courtney Fitzhugh, MD, Mary Link, RN, Wynona Coles, RRT, Deborah Citrin, MD, John F. Tisdale, MD, Matthew M. Hsieh, MD

Blood (2013) 122 (21): 4646.

https://doi.org/10.1182/blood.V122.21.4646.4646

Published: 2013

Journal Articles

Etiology of and Associations with Early Death in Adult Patients with Sickle Cell Disease At a Single Referral Institution.

Courtney Fitzhugh, MD, Darlene Allen, C.L.T., Wynona Coles, Cassie Seamon, RN, Xiongce Zhao, Deepika Darbari, MD, Jonathan Wilson, Meghan Quinn, Matthew Hsieh, MD, Gregory J. Kato, M.D., James G. Taylor, M.D.

Blood (2012) 120 (21): 2117.

https://doi.org/10.1182/blood.V120.21.2117.2117

Published: 2012

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Matthew M Hsieh, Courtney D Fitzhugh, MD, R. Patrick Weitzel, PhD, Wynona Coles, M Beth Link, John F. Tisdale

Blood (2011) 118 (21): 10.

https://doi.org/10.1182/blood.V118.21.10.10

Published: 2011

Journal Articles

Pulmonary Hypertension in Adults and Children with Sickle Cell Disease in Nigeria: Prevalence, Clinical Characteristics and Role of Endemic Tropical Infections.

Zakari Y. Aliyu, MD, MPH, Sachdev Vandana, MD, Aisha I. Mamman, MBBS, Aliyu Babadoko, MBBS, Peter Akpanpe, Ester Attah, Yusuf Suleiman, Nurudeen Aliyu, Jamilu Yusuf, BA, Laurel Mendelsohn, BS, Wynona Coles, BS, Solomon Danbauchi, MBBS, James Taylor, MD, Oswaldo Castro, MD, Victor R. Gordeuk, MD, William C. Blackwelder, MD, Gregory J. Kato, MD, Mark T. Gladwin

Blood (2007) 110 (11): 3793.

https://doi.org/10.1182/blood.V110.11.3793.3793

Published: 2007

Journal Articles

Atorvastatin Therapy Restores Nitric Oxide-Dependent Vascular Responsiveness in Patients with Sickle Cell Disease.

Gregory J. Kato, MD, Christian Hunter, PhD, Lori Hunter, RN, Andre Dejam, MD, PhD, Roberto Machado, MD, Kyle Mack, MD, Jose Villagra, MD, James Nichols, RN, Wynona Coles, RT, Vandana Sachdev, MD, Richard Cannon, MD, Mark T. Gladwin, MD

Blood (2004) 104 (11): 239.

https://doi.org/10.1182/blood.V104.11.239.239

Published: 2004

Journal Articles

Acute on Chronic Pulmonary Hypertension in Patients with Sickle Cell Disease.

Gregory J. Kato, MD, Sabrina Martyr, BS, Roberto Machado, MD, Vandana Sachdev, MD, Inez Ernst, Lori Hunter, RN, Wynona Coles, RT, James Nichols, RN, Christian J. Hunter, PhD, Mark T. Gladwin, MD

Blood (2004) 104 (11): 1669.

https://doi.org/10.1182/blood.V104.11.1669.1669

Published: 2004

NARROW

A Machine Learning-Based Workflow for Predicting Transplant Outcome in Patients with Sickle Cell Disease

Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism

Pentostatin Plus Cyclophosphamide Decrease Graft Rejection in Nonmyeloablative Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease

Bone Marrow Characterization in Sickle Cell Disease: Inflammation and Stress Erythropoiesis Lead to Suboptimal CD34 Recovery Compared to Normal Volunteer Bone Marrow

At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT

At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation

Prevalence of Anti-Human Factor VIII Binding IgG Antibodies in Sickle Cell Disease Patients before and after Hematopoietic Stem Cell Transplantation

Nonmyeloablative Hematopoietic Stem Cell Transplantation Improves a Marker of Diastolic Dysfunction in Patients with Sickle Cell Disease

Therapeutic Hydroxyurea Dosing Is Associated With Decreased Organ Damage and Longer Survival In Adults With Sickle Cell Anemia

Assessment Of The Endocrine Function Of Patients With Sickle Cell Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Etiology of and Associations with Early Death in Adult Patients with Sickle Cell Disease At a Single Referral Institution.

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Pulmonary Hypertension in Adults and Children with Sickle Cell Disease in Nigeria: Prevalence, Clinical Characteristics and Role of Endemic Tropical Infections.

Atorvastatin Therapy Restores Nitric Oxide-Dependent Vascular Responsiveness in Patients with Sickle Cell Disease.

Acute on Chronic Pulmonary Hypertension in Patients with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only